Skip to content

Public FDA record

Z-1561-2021: Remel Bile Esculin Azide Agar w/ 6mcg/ml Vancomycin, Product #R01186, 10/package - Product Usage: use in

Recall record Z-1561-2021 for Remel Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1561-2021
Company in FDA record
Remel Inc
FDA record creation date
May 12, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The media allows growth of E. faecalis ATCC 29212 with blackening of the media.

Source facts

Action
The recalling firm issued customer letters dated 4/22/2021 via first class mail to its direct accounts.
Initiated
2021-04-22
Root cause
Mixed-up of materials/components
Terminated
2023-08-08
Distribution
US Nationwide distribution in the states of AZ, CA, CO, CT, GA, IA, IL, IN, MA, MI, MN, MO, NC, ND, OH, OR, PA, SD, TN, TX, and VA. There was government distribution and no military or foreign distribution.
Recall number
Z-1561-2021
Recall status
Terminated
CDRH record ID
187210
FDA record created
2021-05-12
Recall event number
87830

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗